The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pilot study of first-in-class antimitochondrial metabolism agent, CPI-613, as salvage monotherapy for small cell lung cancer.
 
Thomas Lycan
No Relationships to Disclose
 
Timothy S. Pardee
Consulting or Advisory Role - Johnson & Johnson
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Novartis
Research Funding - Cornerstone Pharmaceuticals
 
William J. Petty
No Relationships to Disclose
 
Ralph D'Agostino
Consulting or Advisory Role - cardioxyl; Cubist; Edwards Lifesciences; Exelixis; Mapp Biopharmaceutical; Novartis; RedHill Biopharma; Rockwell Medical; Target Health
 
Marcelo Raul Bonomi
No Relationships to Disclose
 
Antonius Arthur Miller
No Relationships to Disclose
 
Michael Chan
Consulting or Advisory Role - Novocure
Expert Testimony - Cooney, Scully and Dowling
Travel, Accommodations, Expenses - Novocure
 
Jimmy Ruiz
Consulting or Advisory Role - Clovis Oncology
Research Funding - Roche (Inst)